Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-31 2025-12-31 true Principal activity of company being that of providing support to the charity Heart Cells Foundation.9 true 2025-01-01 false false 9 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10282577 2025-01-01 2025-12-31 10282577 2024-01-01 2024-12-31 10282577 2025-12-31 10282577 2024-12-31 10282577 c:Director1 2025-01-01 2025-12-31 10282577 c:Director2 2025-01-01 2025-12-31 10282577 c:Director3 2025-01-01 2025-12-31 10282577 c:Director4 2025-01-01 2025-12-31 10282577 c:Director5 2025-01-01 2025-12-31 10282577 c:Director6 2025-01-01 2025-12-31 10282577 c:Director7 2025-01-01 2025-12-31 10282577 c:Director8 2025-01-01 2025-12-31 10282577 c:Director9 2025-01-01 2025-12-31 10282577 c:RegisteredOffice 2025-01-01 2025-12-31 10282577 d:CurrentFinancialInstruments 2025-12-31 10282577 d:CurrentFinancialInstruments 2024-12-31 10282577 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 10282577 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 10282577 d:ShareCapital 2025-12-31 10282577 d:ShareCapital 2024-12-31 10282577 d:RetainedEarningsAccumulatedLosses 2025-12-31 10282577 d:RetainedEarningsAccumulatedLosses 2024-12-31 10282577 c:FRS102 2025-01-01 2025-12-31 10282577 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 10282577 c:FullAccounts 2025-01-01 2025-12-31 10282577 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10282577 15 2025-01-01 2025-12-31 10282577 e:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Registered number: 10282577 HEART CELLS COMPANY LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 DECEMBER 2025
HEART CELLS COMPANY LIMITED COMPANY INFORMATION
Directors | M Clasper
| S M James
| Prof A Mathur
| J Rosenberg
| M N Waiman
| J M Mcilroy
| W M Channon
| P Rambech
| M T Rothman
Registered number | 10282577
Registered office | 14th Floor
| 33 Cavendish Square
| London
| W1G 0PW
Accountants | Simmons Gainsford Professional Services Limited
| Chartered Accountants
| 14th Floor
| 33 Cavendish Square
| London
| W1G 0PW
HEART CELLS COMPANY LIMITED CONTENTS
| Page
Balance sheet | 1
Notes to the financial statements | 2 - 3
HEART CELLS COMPANY LIMITED REGISTERED NUMBER: 10282577 BALANCE SHEET AS AT 31 DECEMBER 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Current assets |  |  |  |  |
Cash at bank and in hand | 4 | 7,512 |  | 15,280 |
|  | 7,512 |  | 15,280 |
Creditors: amounts falling due within one year | 5 | (137,169) |  | (103,892) |
Net current liabilities |  |  | (129,657) |  | (88,612)
Total assets less current liabilities |  |  | (129,657) |  | (88,612)
Net liabilities |  |  | (129,657) |  | (88,612)
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 1 |  | 1
Profit and loss account |  |  | (129,658) |  | (88,613)
|  |  | (129,657) |  | (88,612)
The Directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 15 August 2026.
S M James
Directors
The notes on pages 2 to 3 form part of these financial statements. Page 1
HEART CELLS COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. | General information
Heart Cells Company Limited is a private company limited by share capital, incorporated in England and Wales, registration number 10282577. The address of the registered office is 14th Floor, 33 Cavendish Square, London, W1G 0PW. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
| 2.3 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.
| 2.4 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.5 | Financial instruments
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments. Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument. Basic financial assets Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments. Page 2
HEART CELLS COMPANY LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
3. | Employees
| The average monthly number of employees, including directors, during the year was 9 (2024 - 9).
4. | Cash and cash equivalents
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Cash at bank and in hand | 7,512 | 15,280
5. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade creditors | 1,695 | 1,695
| Other creditors | 128,915 | 95,478
| Accruals and deferred income | 6,559 | 6,719
|  | 137,169 | 103,892
6. | Related party transactions
| The company has taken advantage of the exemption provided in FRS 102 Section 1A from disclosing transactions with members of the same group that are wholly owned.
Page 3